STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What does STAT+ cover?
Here’s the breakdown:
Market-moving analysis of pharma and biotech — from startup funding to clinical trial readouts
Developments in health care and technology, including what's new in AI and the latest moves by tech giants
The intersection of Capitol Hill, regulatory agencies, and the life sciences
Reporting on scientific breakthroughs driving drug discovery and pipeline development
What's included with a subscription?
Enjoy an exclusive set of benefits, including:
Daily reporting and analysis
The most comprehensive industry coverage and analysis of the biotech, pharma and health tech industries
Two daily newsletters to brief you on the most important industry news of the day, plus breaking news alerts for need-to-know headlines
Exclusive industry events
Invitations to digital and in-person STAT+ events, plus early-bird access and discounts to industry events around the country
Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
The best reporters in the industry
Our STAT+ newsroom is comprised of some of the nation's most trusted and well-connected health care and financial journalists